Dolutegravir & Lamivudine Tablets

Dolutegravir & Lamivudine Tablets 50/300 MG

Indication

Combination of dolutegravir (integrase strand transfer inhibitor [INSTI]) and lamivudine (nucleoside analogue reverse transcriptase inhibitor [NRTI]) is indicated as a complete regimen for the treatment of human
immunodeficiency virus type 1 (HIV-1) infection.

Pack

30 Tablets Bottle

Category:

Note: Products are not marketed in countries where it is protected by Patent Law